Marshall Wace’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-100
Closed -$24.4K – 3450
2026
Q1
$24.4K Buy
+100
New +$23.3K ﹤0.01% 3036
2024
Q1
– Sell
-105,100
Closed -$16.5M – 2629
2023
Q4
$16.5M Sell
105,100
-7,300
-6% -$1.12M 0.03% 531
2023
Q3
$17.5M Sell
112,400
-16,600
-13% -$2.74M 0.04% 480
2023
Q2
$21.4M Buy
129,000
+25,900
+25% +$4.18M 0.04% 460
2023
Q1
$16M Sell
103,100
-158,400
-61% -$25.6M 0.03% 543
2022
Q4
$46.2M Buy
261,500
+147,800
+130% +$25.5M 0.1% 214
2022
Q3
$18.6M Buy
+113,700
New +$19.2M 0.04% 499
2021
Q4
– Sell
-110,700
Closed -$17.9M – 4086
2021
Q3
$17.9M Buy
+110,700
New +$18.9M 0.07% 299

Other funds holding JNJ

Marshall Wace's JNJ Position: Q3 2026 in Review

Marshall Wace increased its Johnson & Johnson (JNJ) stake by 53% in Q3 2026, buying an estimated $414M and bringing the position to 4,559,795 shares worth $1.21B. The position accounts for 1.06% of the portfolio, ranked #14.

Marshall Wace first reported a position in JNJ in Q1 2014 and has held it in 44 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Marshall Wace held 4,559,795 shares of Johnson & Johnson worth $1.21B as of Q3 2026.
  • Marshall Wace bought 1,570,258 Johnson & Johnson shares in Q3 2026, an estimated $414M.
  • Johnson & Johnson made up 1.06% of Marshall Wace's portfolio in Q3 2026, its #14 holding.
  • Marshall Wace first reported a position in Johnson & Johnson in Q1 2014 and has held it in 44 quarters since.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.